VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy

Kuykendall AT, et al. J Clin Oncol. 2026;Epub ahead of print.

VIEW PUBLICATION